Regeneron Announces Upcoming 2014 Investor Conference Presentations

     Regeneron Announces Upcoming 2014 Investor Conference Presentations

PR Newswire

TARRYTOWN, N.Y., Feb. 14, 2014

TARRYTOWN, N.Y., Feb.14, 2014 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN) will webcast management presentations at the following investor

  o2014 RBC Capital Markets' Global Healthcare Conference at 10:00 a.m.
    Eastern Time on Tuesday, February 25, 2014
  oCowen and Company 34^th Annual Healthcare Conference at 1:30 p.m. Eastern
    Time on Monday, March 3, 2014
  oBarclays Global Healthcare Conference at 1:00 p.m. Eastern Time on
    Tuesday, March 11, 2014

The sessions may be accessed through the Company's web site,, on the 'Events and Presentations' page. Archived versions
of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, oncology,
rheumatoid arthritis, asthma, and atopic dermatitis. For additional
information about the company, please visit

Contact Information:
Manisha Narasimhan, Ph.D.                    Peter Dworkin
Investor Relations    Corporate Communications
914.847.5126 914.847.7640              

SOURCE Regeneron Pharmaceuticals, Inc.

Press spacebar to pause and continue. Press esc to stop.